Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Keith D Kaufman

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Molecular and Cellular Endocrinology|February 8, 2003
Androgens and alopeciaKeith D Kaufman
The Journal of Investigative Dermatology. Symposium Proceedings|August 5, 2003
Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss)Jerry Shapiro, Keith D Kaufman
Annual Review of Medicine|January 22, 2005
Metabolic syndrome: a clinical and molecular perspectiveDavid E Moller, Keith D Kaufman
Journal of the American Academy of Dermatology|June 20, 2006
Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year resultsVera H Price, Emory Menefee, Matilde Sanchez, et al.
European Journal of Dermatology : EJD|January 26, 2002
Finasteride improves male pattern hair loss in a randomized study in identical twinsDow B Stough, Naveen A Rao, Keith D Kaufman, et al.
European Journal of Dermatology : EJD|June 25, 2008
Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss)Keith D Kaufman, Jennifer Rotonda, Arvind K Shah, et al.
Journal of the American Academy of Dermatology|March 22, 2002
Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, dailyVera H Price, Emory Menefee, Matilde Sanchez, et al.
Psychopharmacology|March 2, 2010
Randomized, controlled, double-blind trial of taranabant for smoking cessationMary F Morrison, Paulette Ceesay, Ira Gantz, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 24, 2013
Safety and tolerability of sitagliptin in type 2 diabetes: pooled analysis of 25 clinical studiesSamuel S Engel, Elizabeth Round, Gregory T Golm, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 11, 2013
Erratum to: Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical StudiesSamuel S Engel, Elizabeth Round, Gregory T Golm, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Molecular and Cellular Endocrinology|February 8, 2003
Androgens and alopeciaKeith D Kaufman
The Journal of Investigative Dermatology. Symposium Proceedings|August 5, 2003
Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss)Jerry Shapiro, Keith D Kaufman
Annual Review of Medicine|January 22, 2005
Metabolic syndrome: a clinical and molecular perspectiveDavid E Moller, Keith D Kaufman
Journal of the American Academy of Dermatology|June 20, 2006
Changes in hair weight in men with androgenetic alopecia after treatment with finasteride (1 mg daily): three- and 4-year resultsVera H Price, Emory Menefee, Matilde Sanchez, et al.
European Journal of Dermatology : EJD|January 26, 2002
Finasteride improves male pattern hair loss in a randomized study in identical twinsDow B Stough, Naveen A Rao, Keith D Kaufman, et al.
European Journal of Dermatology : EJD|June 25, 2008
Long-term treatment with finasteride 1 mg decreases the likelihood of developing further visible hair loss in men with androgenetic alopecia (male pattern hair loss)Keith D Kaufman, Jennifer Rotonda, Arvind K Shah, et al.
Journal of the American Academy of Dermatology|March 22, 2002
Changes in hair weight and hair count in men with androgenetic alopecia after treatment with finasteride, 1 mg, dailyVera H Price, Emory Menefee, Matilde Sanchez, et al.
Psychopharmacology|March 2, 2010
Randomized, controlled, double-blind trial of taranabant for smoking cessationMary F Morrison, Paulette Ceesay, Ira Gantz, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|May 24, 2013
Safety and tolerability of sitagliptin in type 2 diabetes: pooled analysis of 25 clinical studiesSamuel S Engel, Elizabeth Round, Gregory T Golm, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 11, 2013
Erratum to: Safety and Tolerability of Sitagliptin in Type 2 Diabetes: Pooled Analysis of 25 Clinical StudiesSamuel S Engel, Elizabeth Round, Gregory T Golm, et al.
Pageof 7